WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

CASE REPORT ON LOSARTAN INDUCED STEVENS JOHNSON SYNDROME

Gikku Mariyam Varghese*, Deepa Koshy and Dr. Abel Abraham Thomas

ABSTRACT

Steven-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) is one of the dermatologic conditions that can be potentially fatal. Steven-Johnson syndrome is an infrequent and a severe form of erythema multiform (EM). It is considered to be a less severe form of toxic epidermal necrolysis (TEN). SJS is most commonly triggered by medications, characterized by extensive necrosis and detachment of the epidermis. SJS can be differentiated from other skin conditions on three clinical criteria, (i) the pattern of individual skin lesions, (ii) distribution of lesions, and (iii) extent of epidermal detachment. Losartan belongs to a group of drugs called angiotensin II receptor antagonists. It keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow. Losartan is used to treat high blood pressure (hypertension). It is also used to lower the risk of stroke in certain people with heart disease. SJS by use of Antihypertensive Drug (Losartan) is rare.

Keywords: Stevens-Johnson Syndrome, Losartan, Cutaneous Reaction.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More